First Affirmative Financial Network’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$234K Buy
+949
New +$241K 0.05% 344
2026
Q1
$268K Buy
+809
New +$275K 0.1% 236
2025
Q3
$247K Buy
+542
New +$221K 0.12% 223

Other funds holding ALNY

First Affirmative Financial Network's ALNY Position: Q3 2026 in Review

First Affirmative Financial Network opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 949 shares worth $234K. The stake represents 0.05% of the portfolio and ranks #344 among its holdings. This is a return to the name: First Affirmative Financial Network previously reported a position in ALNY as recently as Q1 2026.

First Affirmative Financial Network first reported a position in ALNY in Q3 2025 and has held it in 3 quarters since. The position peaked at $268K in Q1 2026. 129 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • First Affirmative Financial Network held 949 shares of Alnylam Pharmaceuticals worth $234K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new First Affirmative Financial Network position in Q3 2026.
  • Alnylam Pharmaceuticals made up 0.05% of First Affirmative Financial Network's portfolio in Q3 2026, its #344 holding.
  • First Affirmative Financial Network first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • First Affirmative Financial Network's Alnylam Pharmaceuticals position peaked at $268K in Q1 2026.
  • 129 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on First Affirmative Financial Network's 13F filing for Q3 2026, filed 21 Oct 2026.